Scientists at The University of Texas at Austin have developed a revolutionary gene-editing method using bacterial retrons ...
The Boston biotech founded by Harvard professor David Sinclair is testing whether cellular reprogramming can turn back the ...
Some of the most expensive drugs currently in use are gene therapies to treat specific diseases, and their high cost limits ...
To solve this critical challenge, he founded Nephrogen in 2022, a biotech startup that uses AI and advanced screening to ...
In 1962, a pediatric neurology resident at Columbia's Neurological Institute and his colleagues in the College of Physicians ...
DURHAM, N.C. (WTVD) -- Duke Eye Center has become the first academic medical center in the country to implant a new ...
Until recently, even the most advanced gene therapies could only be given after a child was born—often racing against time to prevent irreversible damage. In the first part of this series, we explored ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback